Presentation is loading. Please wait.

Presentation is loading. Please wait.

Deficiency of TLR9 does not affect autoantibody levels but shifts autoantibody specificity. Deficiency of TLR9 does not affect autoantibody levels but.

Published byLara Palmeira Modified over 5 years ago

Similar presentations

Presentation on theme: "Deficiency of TLR9 does not affect autoantibody levels but shifts autoantibody specificity. Deficiency of TLR9 does not affect autoantibody levels but."— Presentation transcript:

1 Deficiency of TLR9 does not affect autoantibody levels but shifts autoantibody specificity.
Deficiency of TLR9 does not affect autoantibody levels but shifts autoantibody specificity. WT and Tlr9-/- mice were treated with imiquimod for 3 weeks. Sera were collected and tested for (A) total IgG (WT-control n=5, Tlr9-/--control n=5, WT-imiquimod n=10, Tlr9-/--imiquimod n=10). (B) IgG anti-dsDNA autoantibodies (WT-control n=5, Tlr9-/--control n=4, WT-imiquimod n=10, Tlr9-/--imiquimod n=10). (C) IgG antihistone autoantibodies (WT-control n=5, Tlr9-/--control n=5, WT-imiquimod n=10, Tlr9-/--imiquimod n=10). (D) IgG anti-RNP/Sm autoantibodies (WT-control n=5, Tlr9-/--control n=4, WT-imiquimod n=10, Tlr9-/--imiquimod n=10). (E) Representative images of ANA. WT-control n=4, WT-imiquimod n=10, Tlr9-/--control n=4, Tlr9-/--imiquimod n=10. Bar, 75 µm. *P<0.05, **P<0.01, ***P<0.001, ****P<  TLR, toll-like receptor; WT, wild type. Yudong Liu et al. Lupus Sci Med 2018;5:e000259 ©2018 by Lupus Foundation of America

Download ppt "Deficiency of TLR9 does not affect autoantibody levels but shifts autoantibody specificity. Deficiency of TLR9 does not affect autoantibody levels but."

Similar presentations

Subjects gain SLE classification through Systemic Lupus International Collaborating Clinics (SLICC) criteria of low complement, immunological manifestations.

Subjects gain SLE classification through Systemic Lupus International Collaborating Clinics (SLICC) criteria of low complement, immunological manifestations.
Time between systemic lupus erythematosus (SLE) and haematological malignancy diagnoses. Time between systemic lupus erythematosus (SLE) and haematological.

Time between systemic lupus erythematosus (SLE) and haematological malignancy diagnoses. Time between systemic lupus erythematosus (SLE) and haematological.
The sting of WASP deficiency: autoimmunity exposed

The sting of WASP deficiency: autoimmunity exposed
Time course for laboratory parameters of a patient with systemic lupus erythematosus prior and during bortezomib therapy (arrow). Time course for laboratory.

Time course for laboratory parameters of a patient with systemic lupus erythematosus prior and during bortezomib therapy (arrow). Time course for laboratory.
MR1 inhibits anti-MTg autoantibody responses in CD28−/− NOD

MR1 inhibits anti-MTg autoantibody responses in CD28−/− NOD
Correlation between disease activity and phospho-H2AX levels at G0/G1, S and G2 cell-cycle phases in primary CD3+ T cells and monocytes from patients with.

Correlation between disease activity and phospho-H2AX levels at G0/G1, S and G2 cell-cycle phases in primary CD3+ T cells and monocytes from patients with.
Fig. 5 A competent Fc is required for the antitumor immune response.

Fig. 5 A competent Fc is required for the antitumor immune response.
Stat3C/C mice are more prone to Th17 differentiation. A

Stat3C/C mice are more prone to Th17 differentiation. A
Fig. 8 TLR8 exacerbates disease in the BLM-induced fibrosis model.

Fig. 8 TLR8 exacerbates disease in the BLM-induced fibrosis model.
Volume 25, Issue 3, Pages (September 2006)

Volume 25, Issue 3, Pages (September 2006)
Mean Safety of Estrogens in Lupus Erythematosus National Assessment–Systemic Lupus Erythematosus Disease Activity Index (SELENA-SLEDAI) score at the last.

Mean Safety of Estrogens in Lupus Erythematosus National Assessment–Systemic Lupus Erythematosus Disease Activity Index (SELENA-SLEDAI) score at the last.
Fig. 1. Thorase variants show defects in Thorase oligomer and GluA2-GRIP1 complex disassembly. Thorase variants show defects in Thorase oligomer and GluA2-GRIP1.

Fig. 1. Thorase variants show defects in Thorase oligomer and GluA2-GRIP1 complex disassembly. Thorase variants show defects in Thorase oligomer and GluA2-GRIP1.
Lupus Foundation of America-Rapid Evaluation of Activity in Lupus (LFA-REAL) comprised seven anchored Visual Analogue Scales (0–100 mm each) and can describe.

Lupus Foundation of America-Rapid Evaluation of Activity in Lupus (LFA-REAL) comprised seven anchored Visual Analogue Scales (0–100 mm each) and can describe.
TLR9 deficiency promotes aberrant T cell and myeloid dendritic cell (DC) phenotype in imiquimod-induced autoimmunity. TLR9 deficiency promotes aberrant.

TLR9 deficiency promotes aberrant T cell and myeloid dendritic cell (DC) phenotype in imiquimod-induced autoimmunity. TLR9 deficiency promotes aberrant.
Association of pretreatment interferon (IFN) signature metric (ISM) status with serum autoantibodies, BAFF levels and type I IFN bioactivity. Association.

Association of pretreatment interferon (IFN) signature metric (ISM) status with serum autoantibodies, BAFF levels and type I IFN bioactivity. Association.
Deficiency of TLR9 promotes more severe renal inflammation in imiquimod-induced autoimmunity. Deficiency of TLR9 promotes more severe renal inflammation.

Deficiency of TLR9 promotes more severe renal inflammation in imiquimod-induced autoimmunity. Deficiency of TLR9 promotes more severe renal inflammation.
Figure 3 Laquinimod (LAQ) reduces microglia infiltration and acute axonal damage after 6 weeks of cuprizone Laquinimod (LAQ) reduces microglia infiltration.

Figure 3 Laquinimod (LAQ) reduces microglia infiltration and acute axonal damage after 6 weeks of cuprizone Laquinimod (LAQ) reduces microglia infiltration.
Serum osteopontin (OPN) levels in population-based controls and in cases with SLE. Serum levels of OPN, determined by ELISA, were significantly higher.

Serum osteopontin (OPN) levels in population-based controls and in cases with SLE. Serum levels of OPN, determined by ELISA, were significantly higher.
Neutrophil recruitment to the colonic lamina propria depends on CD4+ T cells. Neutrophil recruitment to the colonic lamina propria depends on CD4+ T cells.

Neutrophil recruitment to the colonic lamina propria depends on CD4+ T cells. Neutrophil recruitment to the colonic lamina propria depends on CD4+ T cells.
Lymphadenopathy (at week 14) in the lpr-water, lpr-CU and lpr-TU groups of mice and ultrasoluble curcumin (UsC) uptake by Epstein–Barr virus (EBV) transformed.

Lymphadenopathy (at week 14) in the lpr-water, lpr-CU and lpr-TU groups of mice and ultrasoluble curcumin (UsC) uptake by Epstein–Barr virus (EBV) transformed.

Similar presentations

Ads by Google